Skip to content
Administration & Dosing

Subcutaneous injection

An injection into the fatty tissue layer between the skin and muscle. The most common administration route for peptides, typically using insulin syringes. Preferred for its slow, steady absorption and ease of self-administration.

Frequently Asked Questions

What is Subcutaneous injection?
An injection into the fatty tissue layer between the skin and muscle. The most common administration route for peptides, typically using insulin syringes. Preferred for its slow, steady absorption and ease of self-administration.
Why is Subcutaneous injection important in peptide research?
Understanding subcutaneous injection is essential for safe and effective peptide use. Proper administration technique directly impacts peptide bioavailability, therapeutic outcomes, and minimizes the risk of adverse effects or contamination.

Related Terms

Intramuscular injection

An injection delivered directly into muscle tissue, providing faster absorption than subcutaneous injection. Used for some peptides when deeper tissue penetration or more rapid onset is desired.

Injection site rotation

The practice of alternating injection locations (abdomen, thigh, upper arm, glute) to prevent lipodystrophy, scar tissue buildup, and localized irritation. Sites should be at least 1 inch apart.

Insulin syringe

A small-volume syringe (typically 0.3mL, 0.5mL, or 1mL) with a fixed fine-gauge needle, originally designed for insulin but widely used for subcutaneous peptide injections. Marked in units (100 units = 1 mL).

Related Peptide Profiles

BPC-157

Body Protection Compound-157, a synthetic pentadecapeptide derived from human gastric juice studied for tissue repair, gut healing, and anti-inflammatory effects.

Semaglutide

A GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and weight management (Wegovy). Reduces appetite and slows gastric emptying.

← Back to full glossary